Preventive effect of berberine against DMBA-induced breast cancer in female Sprague Dawley rats

Biomedicine and Pharmacotherapy

Volumn 92, Issue , 2017, Pages 207-214

  Karnam, Kalyani Chowdary ^a   Ellutla, Maheswara ^a   Bodduluru, Lakshmi Narendra ^a   Kasala, Eshvendar Reddy ^a   Uppulapu, Shravan Kumar ^a   Kalyankumarraju, Malayamarutham ^a   Lahkar, Mangala ^a,b  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b GAUHATI MEDICAL COLLEGE   (India)

Author keywords

Berberine; Breast cancer; Chemoprevention; DMBA; NF B

Indexed keywords

ASCORBIC ACID; BERBERINE; CATALASE; CYCLINE; DIMETHYLBENZ[A]ANTHRACENE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; INTRADUCTAL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; EXPERIMENTAL MAMMARY NEOPLASM; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; TREATMENT OUTCOME; TUMOR VOLUME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BERBERINE; CARCINOGENS; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 85019926345     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.05.069     Document Type: Article

References (50)

1. World Health Organization, GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. 2014 Jan, International Agency for Research on Cancer, Lyon, France.
2. Tirona, M.T., Sehgal, R., Ballester, O., Prevention of breast cancer (part I): epidemiology, risk factors, and risk assessment tools. Cancer Invest. 28:7 (2010), 743–750.
3. Lee, A., Arteaga, C., Smith, I., 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium. Sunday Morning Year-End Review. 2009.
4. Fackenthal, J.D., Olopade, O.I., Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat. Rev. Cancer 7:12 (2007), 937–948.
5. Manoharan, S., Muneeswaran, M., Baskaran, N., Chemopreventive efficacy of berberine in 7,12-dimethylbenz [a] anthracene (DMBA) induced skin carcinogenesis in Swiss albino mice. Int. J. Res. Pharm. Sci. 1 (2010), 521–529.
6. Lee, H.J., Lee, Y.J., Kang, C.M., Bae, S., Jeoung, D., Jang, J.J., Lee, S.S., Cho, C.K., Lee, Y.S., Differential gene signatures in rat mammary tumors induced by DMBA and those induced by fractionated γ radiation. Radiat. Res. 170:5 (2008), 579–590.
7. Jezierska-Drutel, A., Rosenzweig, S.A., Neumann, C.A., Role of oxidative stress and the microenvironment in breast cancer development and progression. Adv. Cancer Res., 119, 2013, 107.
8. Wu, M., Wang, J., Liu, L.T., Advance of studies on anti-atherosclerosis mechanism of berberine. Chin. J. Integrat. Med. 16 (2010), 188–192.
9. Kuo, C.L., Chi, C.W., Liu, T.Y., The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett. 203:2 (2004), 127–137.
10. Kim, J.B., Yu, J.H., Ko, E., Lee, K.W., Song, A.K., Park, S.Y., Shin, I., Han, W., Noh, D.Y., The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine 17:6 (2010), 436–440.
11. Serafim, T.L., Oliveira, P.J., Sardao, V.A., Perkins, E., Parke, D., Holy, J., Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemother. Pharmacol. 61:6 (2008), 1007–1018.
12. Pinto-Garcia, L., Efferth, T., Torres, A., Hoheisel, J.D., Youns, M., Berberine inhibits cell growth and mediates caspase-independent cell death in human pancreatic cancer cells. Planta Med. 76:11 (2010 Aug), 1155–1161.
13. Sun, Y., Xun, K., Wang, Y., Chen, X., A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anti-cancer Drugs 20:9 (2009 Oct 1), 757–769.
14. Meeran, S.M., Katiyar, S., Katiyar, S.K., Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol. Appl. Pharmacol. 229:1 (2008), 33–43.
15. Wu, K., Yang, Q., Mu, Y., Zhou, L., Liu, Y., Zhou, Q., He, B., Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling. Int. J. Oncol., 41(1), 2012, 292.
16. Tsang, C.M., Cheung, Y.C., Lui, V.W., Yip, Y.L., Zhang, G., Lin, V.W., Cheung, K.C., Feng, Y., Tsao, S.W., Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts. BMC Cancer, 13(1), 2013, 619.
17. Madhusudhanan, N., Ignatus, V., Lakshmi, T., Antioxidant activity of berberine on benzopyrene induced experimental lung carcinogenesis in mice. J. Chem. Pharmaceut. Res. 10 (2013), 194–200.
18. Liu, Y., Yu, H., Zhang, C., Cheng, Y., Hu, L., Meng, X., Zhao, Y., Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. Eur. J. Cancer 44:16 (2008), 2425–2432.
19. Liu, Y., Yu, H., Zhang, C., Cheng, Y., Hu, L., Meng, X., Zhao, Y., Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. Eur. J. Cancer 44:16 (2008), 2425–2432.
20. Whitsett, T., Carpenter, M., Lamartiniere, C.A., Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J. Carcinogenesis, 5(1), 2006, 15.
21. Al-Saeedi, F.J., Study of the cytotoxicity of asiaticoside on rats and tumor cells. BMC Cancer, 14(1), 2014, 220.
22. Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analyt. Biochem. 95:2 (1979), 351–358.
23. Sinha, A.K., Colorimetric assay of catalase. Analyt. Biochem. 47:2 (1972), 389–394.
24. Ellman, G.L., Tissue sulfhydryl groups. Archiv. Biochem. Biophys. 82:1 (1959), 70–77.
25. Omaye, S.T., Turnbull, J.D., Sauberlich, H.E., [1] Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol. 62 (1979), 3–11.
26. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72:1–2 (1976), 248–254.
27. Shibata, M.A., Morimoto, J., Shibata, E., Kurose, H., Akamatsu, K., Li, Z.L., Kusakabe, M., Ohmichi, M., Otsuki, Y., Raloxifene inhibits tumor growth and lymph node metastasis in a xenograft model of metastatic mammary cancer. BMC Cancer, 10(1), 2010, 566.
28. Steward, W.P., Brown, K., Cancer chemoprevention: a rapidly evolving field. Br. J. Cancer 109:1 (2013), 1–7.
29. Kensler, T.W., Egner, P.A., Taffe, B.G., Trush, M.A., Role of free radicals in tumor promotion and progression. Progr. Clin. Biol. Res., 298, 1989, 233.
30. Cuzzocrea, S., Riley, D.P., Caputi, A.P., Salvemini, D., Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 53:1 (2001), 135–159.
31. Barros, A.C., Muranaka, E.N., Mori, L.J., Pelizon, C.H., Iriya, K., Giocondo, G., Pinotti, J.A., Induction of experimental mammary carcinogenesis in rats with 7, 12-dimethylbenz (a) anthracene. Revista do Hospital das Clínicas 59:5 (2004), 257–261.
32. Davis, L., Kuttan, G., Effect of Withania somnifera on DMBA induced carcinogenesis. J. Ethnopharmacol. 75:2 (2001), 165–168.
33. Poli, G., Leonarduzzi, G., Biasi, F., Chiarpotto, E., Oxidative stress and cell signalling. Curr. Med. Chem. 11:9 (2004), 1163–1182.
34. Sun, Y., Free radicals, antioxidant enzymes, and carcinogenesis. Free Rad. Biol. Med. 8:6 (1990), 583–599.
35. Druckrey, H., Preussmann, R., Ivankovic, S., Schmähl, D., Organotropic carcinogenic effects of 65 various N-nitroso-compounds on BD rats. Zeitschrift fur Krebsforschung. 69:2 (1966), 103–201.
36. Levine, J.J., Pettei, M.J., Valderrama, E., Gold, D.M., Kessler, B.H., Trachtman, H., Nitric oxide and inflammatory bowel disease: evidence for local intestinal production in children with active colonic disease. J. Pediatr. Gastroenterol. Nutr. 26:1 (1998), 34–38.
37. Ambs, S., Merriam, W.G., Bennett, W.P., Felley-Bosco, E., Ogunfusika, M.O., Oser, S.M., Klein, S., Shields, P.G., Billiar, T.R., Harris, C.C., Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58:2 (1998 Jan 15), 334–341.
38. Kim, H.S., Kwack, S.J., Lee, B.M., Lipid peroxidation, antioxidant enzymes, and benzo [a] pyrene-quinones in the blood of rats treated with benzo [a] pyrene. Chemico-Biol. Interact. 127:2 (2000), 139–150.
39. Meiyanto, E., Hermawan, A., Junedi, S., Fitriasari, A., Susidarti, R.A., Nobiletin increased cytotoxic activity of doxorubicin on MCF-7 cells but not on T47D cells. Int. J. Phytomed., 3(1), 2011, 129.
40. Adly, A.A., Oxidative stress and disease: an updated review. Res. J. Immunol. 3:2 (2010), 129–145.
41. Karaoz, E., Gultekin, F., Akdogan, M., Oncu, M., Gokcimen, A., Protective role of melatonin and a combination of vitamin C and vitamin E on lung toxicity induced by chlorpyrifos-ethyl in rats. Exp. Toxicol. Pathol. 54:2 (2002), 97–108.
42. Connelly, L., Barham, W., Onishko, H.M., Chen, L., Sherrill, T.P., Zabuawala, T., Ostrowski, M.C., Blackwell, T.S., Yull, F.E., NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis model. Breast Cancer Res., 13(4), 2011, R83.
43. Leek, R.D., Landers, R., Fox, S.B., Ng, F., Harris, A.L., Lewis, C.E., Association of tumor necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br. J. Cancer, 77(12), 1998, 2246.
44. Baumgarten, S.C., Frasor, J., Minireview: inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers. Mol. Endocrinol. 26:3 (2012), 360–371.
45. Jin, L., Fuchs, A., Schnitt, S.J., Yao, Y., Joseph, A., Lamszus, K., Park, M., Goldberg, I.D., Rosen, E.M., Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer 79:4 (1997), 749–760.
46. Woo, K.J., Jeong, Y.J., Inoue, H., Park, J.W., Kwon, T.K., Chrysin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression through the inhibition of nuclear factor for IL-6 (NF-IL6) DNA-binding activity. FEBS Lett. 579:3 (2005), 705–711.
47. Khan, M.S., Devaraj, H., Devaraj, N., Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats. Toxicol. Appl. Pharmacol. 251:1 (2011), 85–94.
48. Bodduluru, L.N., Kasala, E.R., Barua, C.C., Karnam, K.C., Dahiya, V., Ellutla, M., Antiproliferative and antioxidant potential of hesperetin against benzo (a) pyrene-induced lung carcinogenesis in Swiss albino mice. Chemico-Biol. Interact. 242 (2015), 345–352.
49. Lv, B., Yang, X., Lv, S., Wang, L., Fan, K., Shi, R., Wang, F., Song, H., Ma, X., Tan, X., Xu, K., CXCR4 signaling induced epithelial-mesenchymal transition by PI3K/AKT and ERK pathways in glioblastoma. Mol. Neurobiol. 52:3 (2015), 1263–1268.
50. Sinha, D., Biswas, J., Sung, B., Aggarwal, B.B., Bishayee, A., Chemopreventive and chemotherapeutic potential of curcumin in breast cancer. Curr. Drug Targets 13:14 (2012), 1799–1819.